Chimeric mouse tumor models reveal differences in pathway activation between ERBB family- and KRAS-dependent lung

Yinghui Zhou1, William M Rideout, Tong Zi

  • 1[1] AVEO Pharmaceuticals, Cambridge, Massachusetts, USA. [2] These authors contributed equally to this work.

Nature Biotechnology
|December 22, 2009
PubMed